Search

Your search keyword '"Wallace, Eli M."' showing total 8 results

Search Constraints

Start Over You searched for: Author "Wallace, Eli M." Remove constraint Author: "Wallace, Eli M." Topic carcinoma, renal cell Remove constraint Topic: carcinoma, renal cell
8 results on '"Wallace, Eli M."'

Search Results

1. 3-[(1 S ,2 S ,3 R )-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma.

2. Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385).

Catalog

Books, media, physical & digital resources

3. Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.

4. Targeting renal cell carcinoma with a HIF-2 antagonist.

5. On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models.

6. A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma.

7. Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma

8. On-Target Efficacy of a HIF2α Antagonist in Preclinical Kidney Cancer Models